Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impact of DR-102 vs standard 28-day oral contraceptive on hemostatic parameters in healthy women
2011-002602-78Phase 2Completed
- Sponsor
- Teva Pharmaceutical Industries Ltd.
- Start
- Jul 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of DR-102, sponsored by Teva Pharmaceutical Industries Ltd.. Started Jul 2011; status: completed.
02
Drugs
DR-102
Beyond the preview
Go deeper on 2011-002602-78.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-002602-78.